A Day in the Life of a Cannabis Nurse

Dawn-Marie Steentra, LPN guides us through a day in the life of a Cannabis Nurse. The work requires ongoing compassion, education, and enthusiasm for patient advocacy.

A history of the Society of Cannabis Clinicians and its contributions and impact on the US medical cannabis movement

Dr. Kevin M.Takakuwa details the history of the SCC, which is the first and oldest U.S. medical organization promoting the use of medical cannabis.

Patients’ Rights Jeopardized in California

Bobby Eisenberg has worked with El Dorado officials to develop regulations that recognize a patient’s right to grow as much cannabis as their doctor authorizes. Now the planning commission in El Dorado Country wants to impose a six-plant limit.

Examining Medical Cannabis Models Worldwide: Access Amidst Lockdown

What would we envision as the best cannabis model for international patient access? This question was explored at a collaborative event in Barcelona just before the COVID-19 lockdowns swept over Spain (and the world).

Cannabis & The COVID-19 Pandemic: A Physician’s Perspective

Joe D. Goldstrich, MD, FACC outlines what we know about the antiviral properties of cannabis and whether or not it could be helpful or detrimental for COVID-19.

Sex, Intimacy, and Cannabis

Sarah Mann, MD separates myth and conjecture from what is known (and unknown) about cannabis and sex. 

The Endocannabinoid System of Animals

This review paper by Dr. Robert Silver gives an overview of the ECS in animals and highlights it as a topic of interest for emerging therapeutics.

Combining Cannabis With Other Herbs

Does cannabis have synergy with other plants? James Brent, DDS reviews the literature.

Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients

An Israeli study identifies associations between the use of cannabinoids and terpenes for symptoms of attention deficit hyperactivity disorder (ADHD).

Response to UK Medical Cannabis Guidelines

Physicians from the UK give their critiques of recent medical cannabis regulations, noting the narrow window of qualifying conditions that do not include chronic pain, as well as advocating for the use of lower-cost, whole-plant flowers for patients.

The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain: How Cannabis Diminished Prescription Opioid Usage

A long-term observational study found cannabis worked as an alternative to prescription opioids in over half of patients with low back pain and an be an adjunct therapy to diminish chronic opioid use for some people.

Report from House of Representatives Hearing “Cannabis Policy – For The New Decade”

Dr. Patricia Frye summarizes a cannabis policy hearing at the House of Representatives. Dr. Frye saw strong bipartisan support for decreasing the barriers to research on cannabis medicine.